PMA P110013S110

Device
Resolute Integrity Zotarolimus Eluting Coronary Stent Systems (hereafter called Resolute Integrity)
Applicant
Medtronic Vascular
PMA number
P110013
Supplement
S110
Product code
NIQ
Decision date
2021-05-11
Generic name
Coronary drug-eluting stent
Approval order statement
Transfer of component extrusion manufacturing operations from the Santa Rosa to the Danvers site.

Current openFDA PMA Record#

Device
Resolute Integrity Zotarolimus Eluting Coronary Stent Systems (hereafter called Resolute Integrity)
Applicant
Medtronic Vascular
PMA number
P110013
Supplement
S110
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2021-05-11
Decision code
OK30
Date received
2021-04-12
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Transfer of component extrusion manufacturing operations from the Santa Rosa to the Danvers site.